ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST BEST-IN-CLASS GPCR DRUG CANDIDATE
10 mai 2022 13h03 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs),...